Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tofacitinib in Chronic Plaque Psoriasis
NCT00678561Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of INN-04-01 in plaque psoriasis, sponsored by Pfizer. Started Oct 2008; status: completed.
02
Drugs
INN-04-01
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00678561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00678561.